EVOK Evoke Pharma Inc.

0.61
0  0%
Previous Close 0.6
Open 0.6
Price To Book 4.67
Market Cap 14124474
Shares 23,261,650
Volume 363,695
Short Ratio
Av. Daily Volume 1,033,393

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued April 2, 2019.
Gimoti - EVK-001
Female diabetic gastroparesis

Latest News

  1. Evoke Pharma Reports First Quarter 2019 Financial Results
  2. Evoke Pharma (EVOK) to Post Q1 Earnings: What's in Store?
  3. Investors Who Bought Evoke Pharma (NASDAQ:EVOK) Shares Five Years Ago Are Now Down 92%
  4. Dr. Reddy's (RDY) Inks Deal to Acquire Portfolio of 42 ANDAs
  5. The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings
  6. Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti™ NDA
  7. Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates
  8. Evoke Pharma Submits Response to FDA Review Letter for Gimoti™ NDA
  9. Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication
  10. Evoke Pharma Receives Preliminary FDA Communication on Gimoti™ NDA
  11. Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
  12. Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners
  13. Loss-Making Evoke Pharma, Inc. (NASDAQ:EVOK) Expected To Breakeven
  14. Evoke Pharma Reports Third Quarter 2018 Results
  15. Shareholders Should Check The Ownership Structure Of Evoke Pharma Inc (NASDAQ:EVOK)
  16. Generic-Drugs Stock Outlook: No Respite from Pricing Issues
  17. Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead
  18. Evoke Pharma (EVOK) Announces FDA Acceptance of Gimoti NDA